DERMAL REPLACEMENT WITH MATRIDERM - FIRST EXPERIENCE AT THE PRAGUE BURN CENTRE

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Dermatology

Background:

• Scar quality significantly impacts patient recovery and functional reintegration.
• Artificial skin substitutes enhance functional and cosmetic outcomes for diverse patient populations.
• Effective wound management is crucial for restoring normal life post-injury.

Purpose of the Study:

• To evaluate the efficacy of Matriderm® as a dermal substitute in treating acute skin loss.
• To present initial clinical experience with Matriderm® in a cohort of 10 patients.
• To assess functional and cosmetic outcomes following Matriderm® application.

Main Methods:

• Utilized Matriderm®, a collagen elastin dermal substitute, for immediate application with skin grafts.
• Treated 10 patients with skin losses from various etiologies.
• Monitored healing time and assessed for infectious complications and functional results.

Main Results:

• Average healing time observed was 19.6 days.
• Treatment proceeded without significant infectious complications.
• Good functional results were achieved in all treated patients.

Conclusions:

• Matriderm® serves as a effective alternative to Integra® for acute skin loss treatment.
• The collagen elastin dermal substitute is suitable for reconstructive surgery.
• Matriderm® facilitates improved patient outcomes in managing diverse skin defects.